Cover Image

Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants

Saved in:

Bibliographic Details
Main Authors:	Bin Tu (Author), Huiyuan Wang (Author), Xinran An (Author), Jingkun Qu (Author), Qianqian Li (Author), Yanrong Gao (Author), Mingjie Shi (Author), Hong Qiu (Author), Yongzhuo Huang (Author)
Format:	Book
Published:	Elsevier, 2022-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Localized delivery of nanomedicine and antibodies for combating COVID-19
by: Bin Tu, et al.
Published: (2023)

Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
by: Canhao Wu, et al.
Published: (2022)

Author correction to "Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles" [Acta Pharmaceutica Sinica B 12 (2022) 1523-1533]
by: Canhao Wu, et al.
Published: (2023)

Lipid Metabolism Regulation Based on Nanotechnology for Enhancement of Tumor Immunity
by: Bin Tu, et al.
Published: (2022)

Nanodecoys: A Quintessential Candidate to Augment Theranostic Applications for a Plethora of Diseases
by: Sampreeti Chatterjee, et al.
Published: (2022)

On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024)

The toxicokinetic profile of Dex40-GTMAC3 - a novel polysaccharide candidate for reversal of unfractionated heparin.
by: Emilia eSokolowska, et al.
Published: (2016)

Decoding the next SARS-CoV-2 variant
by: Jeremy Nel, et al.
Published: (2022)

Accurate construction of cell membrane biomimetic graphene nanodecoys via purposeful surface engineering to improve screening efficiency of active components of traditional Chinese medicine
by: Qi Hu, et al.
Published: (2022)

Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
by: Qianqian Cui, et al.
Published: (2023)

Omicron variant in the current SARS-CoV-2 pandemic
by: Kaveh Nasiri, et al.
Published: (2022)

The Emergence and Spread of Novel SARS-CoV-2 Variants
by: Huaimin Yi, et al.
Published: (2021)

Immune Profile of SARS-CoV-2 Variants of Concern
by: Caterina A. M. La Porta, et al.
Published: (2021)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
by: Khan Sharun, et al.
Published: (2021)

Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics
by: Anna Maria Piras, et al.
Published: (2020)

Coronavirus spike protein-based vaccines. Vaccine delivery systems
by: Akmal M. Asrorov, et al.
Published: (2024)

SARS-COV-2 Notable Mutations and Variants: A Review Article
by: Dariush Farhud, et al.
Published: (2022)

Different SARS-CoV-2 variants, same prevention strategies
by: Tafadzwa Dzinamarira, et al.
Published: (2022)

Screening for inhibitors against SARS-CoV-2 and its variants
by: Weijing Yuan, et al.
Published: (2022)

Importation of SARS-CoV-2 Omicron variant in Beijing, China
by: Fu Li, et al.
Published: (2022)

Are the new SARS-CoV-2 variants resistant against the vaccine?
by: Mohnad Abdalla, et al.
Published: (2021)

Genetic variants of SARS-CoV-2 and its clinical implications
by: Alexander Expósito Lara, et al.
Published: (2021)

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
by: Josephine Wambani, et al.
Published: (2022)

Critically ill infants with SARS-COV-2 delta variant infection
by: Aida Borgi, et al.
Published: (2023)

Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant
by: Nirmitee Mulgaonkar, et al.
Published: (2023)

Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection
by: Tushar Saha, et al.
Published: (2023)

A comparison of severity of illness between the SARS-CoV-2 Omicron variant and Delta variant
by: Laura Peyton Ellis, et al.
Published: (2023)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

Early detection of SARS-CoV-2 variants through dynamic co-mutation network surveillance
by: Qiang Huang, et al.
Published: (2023)

The association between inhaled corticosteroid and the risks of SARS-COV-2 infection: A systematic review and meta-analysis
by: Chao-Hsien Chen, et al.
Published: (2023)

Blocking the action of NLRP3 inflammasome by inhaled ibuprofenate on pulmonary macrophages infected by SARS‐CoV‐2
by: Christian Carlos Zurita‐Lizza, et al.
Published: (2023)

An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro
by: Davide D'Angelo, et al.
Published: (2023)

Differences in case-fatality-rate of emerging SARS-CoV-2 variants
by: Jing Liu, et al.
Published: (2023)

Transmission dynamics of SARS-CoV-2 variants in the Brazilian state of Pará
by: Catarina T. Pinho, et al.
Published: (2023)

The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
by: Lixin Lin, et al.
Published: (2021)

Geographical Distribution of Genetic Variants and Lineages of SARS-CoV-2 in Chile
by: Andrés E. Castillo, et al.
Published: (2020)

How to Deal With Vaccine Breakthrough Infection With SARS-CoV-2 Variants
by: Ying Guo, et al.
Published: (2022)

Dynamics of SARS-CoV-2 Variants of Concern in Brazil, Early 2021
by: José Eduardo Levi, et al.
Published: (2021)

What is Currently Known About the SARS-CoV2 Variants of Concern
by: Tarek Souaid, et al.
Published: (2021)

Observations on the current outbreak of the SARS-CoV-2 Delta Variant in Sydney
by: Rick Nunes-Vaz, et al.
Published: (2021)